Cure My Disease

Don't miss your cure!

 Log in / Sign up

Double surgery combo may help glaucoma patients see better outcomes

NCT ID NCT07073937

ENROLLING_BY_INVITATION Disease control Sponsor: University of Utah Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study reviews 100 patients with open-angle glaucoma who had two minimally invasive surgeries (Hydrus microstent and iTrack canaloplasty) along with cataract surgery. Researchers want to see if this combination lowers eye pressure and reduces the need for glaucoma medications over three years. The goal is to find a more effective surgical approach for managing glaucoma.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Hydrus microstent and iTrack canaloplasty (surgical procedures)
What this could lead to
If successful, this could show that combining these two surgeries is more effective at lowering eye pressure and reducing medication use than cataract surgery alone.
What could go wrong
This is a small, retrospective chart review, not a controlled trial. Results may not apply to all patients, and the study cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANALOPLASTY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma ocular hypertension open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANALOPLASTY CATARACT SURGERY GLAUCOMA GLAUCOMA, OPEN-ANGLE INTRAOCULAR PRESSURE (IOP) MIGS MINIMALLY INVASIVE GLAUCOMA SURGERY MINIMALLY INVASIVE SURGICAL TECHNIQUE SURGICAL TECHNIQUE

Contacts and locations

Locations

  • University of Utah John A. Moran Eye Center

    Salt Lake City, Utah, 84132, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.